Trial intelligence / Profile preview

Jiuwei Zhenxin Granules versus paroxetine for generalized anxiety disorder

ChiCTR2100042771Phase 4Completed

Sponsor
Beijing Anding Hospital
Start
Oct 2012
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of jiuwei zhenxin in generalized anxiety disorder (GAD) (2 arms), sponsored by Beijing Anding Hospital. Primary endpoint: HAMA total score. Started Oct 2012; status: completed.

02

Drugs

jiuwei zhenxin
03

Conditions

generalized anxiety disorder (GAD)

Beyond the preview

Go deeper on ChiCTR2100042771.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100042771.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call